ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma-Reference-Cited by-同舟云学术

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma

Published:2005-05 Issue: Volume:16 Page:i45-i47
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Harrouseau J.-L.,Greil R.,Kloke O.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/suppl_1/i45/966624/mdi818.pdf

Reference11 articles.

1. The treatment of multiple myeloma;Alexanian;N Engl J Med,1994

2. A clinical staging system for multiple myeloma;Durie;Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer,1975

3. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation;Durie;Hematol J,2003

4. Serum β2 microglobulin and survival duration in multiple myeloma: a single reliable marker for staging;Bataille;Br J Haematol,1983

5. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013;PLOS ONE;2018-12-05

2. Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice;European Journal of Haematology;2018-09-05

3. The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey;European Journal of Cancer Care;2016-04-12

4. Bone disease;Handbook of Multiple Myeloma;2015

5. Cancer-associated bone disease;Osteoporosis International;2013-10-22